IDEXX Laboratories Inc.

NASDAQ: IDXXHealthcare / Diagnostic Substances / USA
273.26-5.62-2.02%Vol 133 7731Y Perf 24.57%
Oct 22nd, 2019 15:32
BID273.17 ASK273.54
Open279.07 Previous Close278.88
Pre-Market- After-Trading278.88
 - -%  - -%
Target Price
282.75 
Analyst Rating
Strong Buy 1.33
Potencial %
3.40 
Finscreener Ranking
     39.18
Insiders Trans % 3/6/12M
-89/-90/-93 
Value Ranking
     36.40
Insiders Value % 3/6/12M
-99/-99/-97 
Growth Ranking
★★★+     53.36
Insiders Shares Cnt. % 3/6/12M
-99/-99/-97 
Income Ranking
 —    -
Market Cap (mil)23 525 
Earnings Rating
Sell
Price Range Ratio 52wk %
83.71 
Earnings Date
31st Oct 2019

Today's Price Range

272.88280.02

52wk Range

176.11292.17

5 Year PE Ratio Range

30.1087.10

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-1.20%
1 Month
1.72%
3 Months
-2.85%
6 Months
25.85%
1 Year
24.57%
3 Years
152.43%
5 Years
347.14%
10 Years
960.38%

Name / TickerPriceChg.Chg.%
IDXX273.26-5.6200-2.02
AAPL240.920.41000.17
GOOG1 243.56-2.5900-0.21
MSFT137.06-1.3700-0.99
XOM69.390.65000.95
WFC50.790.33000.65
JNJ129.401.38001.08
FB183.40-6.3600-3.35
GE8.990.20002.28
JPM124.921.37001.11
Earnings HistoryEstimateReportedSurprise %
Q02 20191.371.434.38
Q01 20191.041.1712.50
Q04 20180.900.988.89
Q03 20180.981.057.14
Q02 20181.181.234.24
Q01 20180.931.018.60
Q04 20170.730.775.48
Q03 20170.750.795.33
Earnings Per EndEstimateRevision %Trend
9/2019 QR1.13-2.59Negative
12/2019 QR1.120.00-
12/2019 FY4.860.83Positive
12/2020 FY5.570.00-
Next Report Date31st Oct 2019
Estimated EPS Next Report1.13
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume133 773
Shares Outstanding (in ths.)86 090
Trades Count557
Dollar Volume19 261 052
Avg. Volume437 262
Avg. Weekly Volume230 352
Avg. Monthly Volume296 413
Avg. Quarterly Volume374 947
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (83.33 %)
5 (83.33 %)
5 (83.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (16.67 %)
1 (16.67 %)
1 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.33
Strong Buy
1.33
Strong Buy
1.33

IDEXX Laboratories Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. Idexx gets about 39% of its revenue from outside the United States.

CEO: Jonathan W. Ayers

Teplephone: +1 207 556-0300

Address: One IDEXX Drive, Westbrook 04092, ME, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

43%57%

Bearish Bullish

51%49%

Bearish Bullish

49%51%

News